Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
$13.26M
26 trades · 6 insiders
Net · 90d
$-13.26M
Insiders on file
29
Daily buy vs sell · 90 days
■ Open-market buys (P) ■ Open-market sales (S) · daily dollar value by transaction date
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Sanzone Virginia Ruth | VP, General Counsel | 143 | $0 | $6.67M | 2026-09-03 |
| Bonnell Brian Michael | Chief Financial Officer | 79 | $0 | $5.45M | 2026-09-01 |
| Woolson Daniel | VP, GM-Infusion Capital | 98 | $0 | $4.50M | 2026-08-13 |
| Sousa Ben | Chief Information Officer | 39 | $0 | $1.29M | 2026-08-12 |
| Voigtlander Christian B. | Chief Operating Officer | 152 | $0 | $16.88M | 2026-08-11 |
| FINNEY ELISHA W | Director | 56 | $0 | $1.24M | 2026-08-11 |
| Hernandez Laurie | Director | 18 | $0 | $0 | 2026-05-13 |
| Greenberg David C. | Director | 53 | $151.7K | $730.6K | 2026-05-13 |
| Abbey Donald | Director | 31 | $0 | $0 | 2026-05-13 |
| KENNEDY KOLLEEN T | Director | 18 | $0 | $0 | 2026-05-13 |
| Hoffmeister David F | Director | 30 | $0 | $0 | 2026-05-13 |
| Jain Vivek | Chairman and CEO | 307 | $4.24M | $110.86M | 2026-03-15 |
| LOPEZ GEORGE A | Director, 10% Owner | 528 | $6.33M | $195.26M | 2024-03-14 |
| Smiths Group International Holdings Ltd | Other | 1 | $0 | $88.05M | 2024-02-29 |
| SMITHS GROUP PLC | Other | 1 | $0 | $88.05M | 2024-02-29 |
| McGrody Kevin J | Controller | 103 | $0 | $3.47M | 2022-03-08 |
| SWINNEY ROBERT S | Director | 157 | $0 | $9.42M | 2021-09-15 |
| Lamb Scott E | Secretary, Treasurer, | 138 | $0 | $35.93M | 2020-02-14 |
| McCall Thomas D | Vice President and Gen'l Mgr. | 68 | $0 | $5.94M | 2020-01-17 |
| BURCAR ALISON D | Vice President and Gen'l Mgr. | 158 | $0 | $39.03M | 2019-03-27 |
| C.P. Pharmaceuticals International C.V. | Other | 1 | $0 | $523.13M | 2018-11-15 |
| Pfizer Production LLC | 10% Owner | 1 | $0 | $199.05M | 2018-08-13 |
| SAUCEDO JOSEPH R | Director | 122 | $0 | $8.43M | 2018-05-14 |
| RIGGS STEVEN | Vice President Operations | 174 | $0 | $31.15M | 2018-02-11 |
| SHERMAN RICHARD MD | Director | 92 | $0 | $4.61M | 2017-05-16 |
| BROWN JACK | Director | 55 | $0 | $652.4K | 2015-10-05 |
| CONNORS JOHN J | Director | 51 | $0 | $2.89M | 2015-06-15 |
| KOVALCHIK MICHAEL T | Director | 40 | $0 | $1.81M | 2014-05-09 |
| COSTELLO RICHARD A | Vice President Sales | 82 | $0 | $8.65M | 2014-02-25 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Sanzone Virginia Ruth | VP, General Counsel | S Sale | 2026-09-03 | 2026-09-03 | 1,238 | $168.44 | $208.5K | 16,020 | SEC↗ |
| Sanzone Virginia Ruth | VP, General Counsel | S Sale | 2026-09-03 | 2026-09-03 | 724 | $169.53 | $122.7K | 15,296 | SEC↗ |
| Sanzone Virginia Ruth | VP, General Counsel | S Sale | 2026-09-03 | 2026-09-03 | 692 | $171.52 | $118.7K | 14,604 | SEC↗ |
| Sanzone Virginia Ruth | VP, General Counsel | S Sale | 2026-09-03 | 2026-09-03 | 2,202 | $167.67 | $369.2K | 17,258 | SEC↗ |
| Sanzone Virginia Ruth | VP, General Counsel | S Sale | 2026-09-03 | 2026-09-03 | 692 | $171.51 | $118.7K | 14,604 | SEC↗ |
| Sanzone Virginia Ruth | VP, General Counsel | S Sale | 2026-09-03 | 2026-09-03 | 724 | $169.53 | $122.7K | 15,296 | SEC↗ |
| Sanzone Virginia Ruth | VP, General Counsel | S Sale | 2026-09-03 | 2026-09-03 | 1,238 | $168.44 | $208.5K | 16,020 | SEC↗ |
| Sanzone Virginia Ruth | VP, General Counsel | S Sale | 2026-09-03 | 2026-09-03 | 2,202 | $167.67 | $369.2K | 17,258 | SEC↗ |
| Bonnell Brian Michael | Chief Financial Officer | S Sale | 2026-09-01 | 2026-09-01 | 6,381 | $175.00 | $1.12M | 56,062 | SEC↗ |
| Bonnell Brian Michael | Chief Financial Officer | S Sale | 2026-09-01 | 2026-09-01 | 6,381 | $175.00 | $1.12M | 56,062 | SEC↗ |
| Bonnell Brian Michael | Chief Financial Officer | S Sale | 2026-08-31 | 2026-08-31 | 4,568 | $173.44 | $792.3K | 63,556 | SEC↗ |
| Bonnell Brian Michael | Chief Financial Officer | S Sale | 2026-08-31 | 2026-08-31 | 1,712 | $171.05 | $292.8K | 70,038 | SEC↗ |
| Bonnell Brian Michael | Chief Financial Officer | S Sale | 2026-08-31 | 2026-08-31 | 1,914 | $172.12 | $329.4K | 68,124 | SEC↗ |
| Bonnell Brian Michael | Chief Financial Officer | S Sale | 2026-08-31 | 2026-08-31 | 1,113 | $173.91 | $193.6K | 62,443 | SEC↗ |
| Bonnell Brian Michael | Chief Financial Officer | S Sale | 2026-08-31 | 2026-08-31 | 1,113 | $173.91 | $193.6K | 62,443 | SEC↗ |
| Bonnell Brian Michael | Chief Financial Officer | S Sale | 2026-08-31 | 2026-08-31 | 4,568 | $173.44 | $792.3K | 63,556 | SEC↗ |
| Bonnell Brian Michael | Chief Financial Officer | S Sale | 2026-08-31 | 2026-08-31 | 1,914 | $172.12 | $329.4K | 68,124 | SEC↗ |
| Bonnell Brian Michael | Chief Financial Officer | S Sale | 2026-08-31 | 2026-08-31 | 1,712 | $171.05 | $292.8K | 70,038 | SEC↗ |
| Woolson Daniel | VP, GM-Infusion Capital | S Sale | 2026-08-13 | 2026-08-13 | 5,417 | $181.33 | $982.3K | 17,062 | SEC↗ |
| Woolson Daniel | VP, GM-Infusion Capital | S Sale | 2026-08-13 | 2026-08-13 | 5,417 | $181.33 | $982.3K | 17,062 | SEC↗ |
| Sousa Ben | Chief Information Officer | S Sale | 2026-08-12 | 2026-08-12 | 2,250 | $178.32 | $401.2K | 3,076 | SEC↗ |
| Sousa Ben | Chief Information Officer | S Sale | 2026-08-12 | 2026-08-12 | 2,250 | $178.32 | $401.2K | 3,076 | SEC↗ |
| FINNEY ELISHA W | Director | S Sale | 2026-08-11 | 2026-08-11 | 378 | $182.48 | $69.0K | 4,871 | SEC↗ |
| Voigtlander Christian B. | Chief Operating Officer | S Sale | 2026-08-11 | 2026-08-11 | 8,929 | $182.93 | $1.63M | 37,377 | SEC↗ |
| Voigtlander Christian B. | Chief Operating Officer | S Sale | 2026-08-11 | 2026-08-11 | 8,929 | $182.93 | $1.63M | 37,377 | SEC↗ |
| FINNEY ELISHA W | Director | S Sale | 2026-08-11 | 2026-08-11 | 378 | $182.48 | $69.0K | 4,871 | SEC↗ |
| Woolson Daniel | President | S Sale | 2026-05-22 | 2026-05-22 | 2,123 | $132.21 | $280.7K | 22,479 | SEC↗ |
| Sanzone Virginia Ruth | VP, General Counsel | S Sale | 2026-05-14 | 2026-05-15 | 2,447 | $124.08 | $303.6K | 19,460 | SEC↗ |
| Greenberg David C. | Director | M Exercise deriv | 2026-05-13 | 2026-05-13 | 1,254 | — | $0 | 0 | SEC↗ |
| Greenberg David C. | Director | A Award deriv | 2026-05-13 | 2026-05-13 | 1,475 | — | $0 | 1,475 | SEC↗ |
| Hoffmeister David F | Director | A Award deriv | 2026-05-13 | 2026-05-13 | 1,475 | — | $0 | 1,475 | SEC↗ |
| Hoffmeister David F | Director | M Exercise deriv | 2026-05-13 | 2026-05-13 | 1,254 | — | $0 | 0 | SEC↗ |
| Abbey Donald | Director | A Award deriv | 2026-05-13 | 2026-05-13 | 1,475 | — | $0 | 1,475 | SEC↗ |
| Abbey Donald | Director | M Exercise deriv | 2026-05-13 | 2026-05-13 | 1,254 | — | $0 | 0 | SEC↗ |
| FINNEY ELISHA W | Director | A Award deriv | 2026-05-13 | 2026-05-13 | 1,475 | — | $0 | 1,475 | SEC↗ |
| FINNEY ELISHA W | Director | M Exercise deriv | 2026-05-13 | 2026-05-13 | 1,254 | — | $0 | 0 | SEC↗ |
| Hernandez Laurie | Director | A Award deriv | 2026-05-13 | 2026-05-13 | 1,475 | — | $0 | 1,475 | SEC↗ |
| Hernandez Laurie | Director | M Exercise deriv | 2026-05-13 | 2026-05-13 | 1,254 | — | $0 | 0 | SEC↗ |
| KENNEDY KOLLEEN T | Director | A Award deriv | 2026-05-13 | 2026-05-13 | 1,475 | — | $0 | 1,475 | SEC↗ |
| KENNEDY KOLLEEN T | Director | M Exercise deriv | 2026-05-13 | 2026-05-13 | 1,254 | — | $0 | 0 | SEC↗ |
| Greenberg David C. | Director | M Exercise | 2026-05-13 | 2026-05-13 | 1,254 | — | $0 | 9,214 | SEC↗ |
| Hoffmeister David F | Director | M Exercise | 2026-05-13 | 2026-05-13 | 1,254 | — | $0 | 6,004 | SEC↗ |
| Abbey Donald | Director | M Exercise | 2026-05-13 | 2026-05-13 | 1,254 | — | $0 | 6,004 | SEC↗ |
| FINNEY ELISHA W | Director | M Exercise | 2026-05-13 | 2026-05-13 | 1,254 | — | $0 | 5,249 | SEC↗ |
| Hernandez Laurie | Director | M Exercise | 2026-05-13 | 2026-05-13 | 1,254 | — | $0 | 4,862 | SEC↗ |
| KENNEDY KOLLEEN T | Director | M Exercise | 2026-05-13 | 2026-05-13 | 1,254 | — | $0 | 4,539 | SEC↗ |
| Greenberg David C. | Director | M Exercise deriv | 2026-05-12 | 2026-05-13 | 2,424 | — | $0 | 0 | SEC↗ |
| Greenberg David C. | Director | S Sale | 2026-05-12 | 2026-05-13 | 2,424 | $122.91 | $297.9K | 7,960 | SEC↗ |
| Greenberg David C. | Director | M Exercise | 2026-05-12 | 2026-05-13 | 2,424 | $101.06 | $245.0K | 10,384 | SEC↗ |
| Abbey Donald | Director | J Other | 2026-03-25 | 2026-03-26 | 704 | — | $0 | 4,046 | SEC↗ |
| Bonnell Brian Michael | Chief Financial Officer | M Exercise deriv | 2026-03-15 | 2026-03-16 | 3,248 | — | $0 | 0 | SEC↗ |
| Bonnell Brian Michael | Chief Financial Officer | M Exercise deriv | 2026-03-15 | 2026-03-16 | 11,400 | — | $0 | 0 | SEC↗ |
| Jain Vivek | Chairman and CEO | M Exercise deriv | 2026-03-15 | 2026-03-16 | 17,100 | — | $0 | 0 | SEC↗ |
| Jain Vivek | Chairman and CEO | M Exercise deriv | 2026-03-15 | 2026-03-16 | 4,872 | — | $0 | 0 | SEC↗ |
| Sanzone Virginia Ruth | VP, General Counsel | M Exercise deriv | 2026-03-15 | 2026-03-16 | 5,700 | — | $0 | 0 | SEC↗ |
| Sanzone Virginia Ruth | VP, General Counsel | M Exercise deriv | 2026-03-15 | 2026-03-16 | 1,624 | — | $0 | 0 | SEC↗ |
| Sousa Ben | Chief Information Officer | M Exercise deriv | 2026-03-15 | 2026-03-16 | 1,300 | — | $0 | 0 | SEC↗ |
| Woolson Daniel | VP, GM-Infusion Capital | M Exercise deriv | 2026-03-15 | 2026-03-16 | 2,924 | — | $0 | 0 | SEC↗ |
| Voigtlander Christian B. | Chief Operating Officer | M Exercise deriv | 2026-03-15 | 2026-03-16 | 3,248 | — | $0 | 0 | SEC↗ |
| Voigtlander Christian B. | Chief Operating Officer | M Exercise deriv | 2026-03-15 | 2026-03-16 | 11,400 | — | $0 | 0 | SEC↗ |
| Bonnell Brian Michael | Chief Financial Officer | F Tax w/h | 2026-03-15 | 2026-03-16 | 1,795 | $125.85 | $225.9K | 71,750 | SEC↗ |
| Bonnell Brian Michael | Chief Financial Officer | M Exercise | 2026-03-15 | 2026-03-16 | 11,400 | — | $0 | 76,097 | SEC↗ |
| Bonnell Brian Michael | Chief Financial Officer | F Tax w/h | 2026-03-15 | 2026-03-16 | 5,800 | $125.85 | $729.9K | 70,297 | SEC↗ |
| Bonnell Brian Michael | Chief Financial Officer | M Exercise | 2026-03-15 | 2026-03-16 | 3,248 | — | $0 | 73,545 | SEC↗ |
| Jain Vivek | Chairman and CEO | F Tax w/h | 2026-03-15 | 2026-03-16 | 9,452 | $125.85 | $1.19M | 124,654 | SEC↗ |
| Jain Vivek | Chairman and CEO | M Exercise | 2026-03-15 | 2026-03-16 | 4,872 | — | $0 | 129,526 | SEC↗ |
| Jain Vivek | Chairman and CEO | F Tax w/h | 2026-03-15 | 2026-03-16 | 2,693 | $125.85 | $338.9K | 126,833 | SEC↗ |
| Jain Vivek | Chairman and CEO | M Exercise | 2026-03-15 | 2026-03-16 | 17,100 | — | $0 | 134,106 | SEC↗ |
| Sanzone Virginia Ruth | VP, General Counsel | M Exercise | 2026-03-15 | 2026-03-16 | 5,700 | — | $0 | 24,330 | SEC↗ |
| Sanzone Virginia Ruth | VP, General Counsel | F Tax w/h | 2026-03-15 | 2026-03-16 | 3,150 | $125.85 | $396.4K | 21,180 | SEC↗ |
| Sanzone Virginia Ruth | VP, General Counsel | M Exercise | 2026-03-15 | 2026-03-16 | 1,624 | — | $0 | 22,804 | SEC↗ |
| Sanzone Virginia Ruth | VP, General Counsel | F Tax w/h | 2026-03-15 | 2026-03-16 | 897 | $125.85 | $112.9K | 21,907 | SEC↗ |
| Sousa Ben | Chief Information Officer | F Tax w/h | 2026-03-15 | 2026-03-16 | 718 | $125.85 | $90.4K | 5,326 | SEC↗ |
| Sousa Ben | Chief Information Officer | M Exercise | 2026-03-15 | 2026-03-16 | 1,300 | — | $0 | 6,044 | SEC↗ |
| Woolson Daniel | VP, GM-Infusion Capital | F Tax w/h | 2026-03-15 | 2026-03-16 | 1,295 | $125.85 | $163.0K | 24,602 | SEC↗ |
| Woolson Daniel | VP, GM-Infusion Capital | M Exercise | 2026-03-15 | 2026-03-16 | 2,924 | — | $0 | 25,897 | SEC↗ |
| Voigtlander Christian B. | Chief Operating Officer | M Exercise | 2026-03-15 | 2026-03-16 | 11,400 | — | $0 | 51,154 | SEC↗ |
| Voigtlander Christian B. | Chief Operating Officer | M Exercise | 2026-03-15 | 2026-03-16 | 3,248 | — | $0 | 48,101 | SEC↗ |
| Voigtlander Christian B. | Chief Operating Officer | F Tax w/h | 2026-03-15 | 2026-03-16 | 6,301 | $125.85 | $793.0K | 44,853 | SEC↗ |
| Voigtlander Christian B. | Chief Operating Officer | F Tax w/h | 2026-03-15 | 2026-03-16 | 1,795 | $125.85 | $225.9K | 46,306 | SEC↗ |
| Voigtlander Christian B. | Chief Operating Officer | M Exercise deriv | 2026-03-08 | 2026-03-09 | 71,757 | — | $0 | 0 | SEC↗ |
| Woolson Daniel | VP, GM-Infusion Capital | M Exercise deriv | 2026-03-08 | 2026-03-09 | 16,147 | — | $0 | 0 | SEC↗ |
| Woolson Daniel | VP, GM-Infusion Capital | M Exercise deriv | 2026-03-08 | 2026-03-09 | 2,153 | — | $0 | 6,908 | SEC↗ |
| Sanzone Virginia Ruth | VP, General Counsel | M Exercise deriv | 2026-03-08 | 2026-03-09 | 23,917 | — | $0 | 0 | SEC↗ |
| Sanzone Virginia Ruth | VP, General Counsel | M Exercise deriv | 2026-03-08 | 2026-03-09 | 3,189 | — | $0 | 7,886 | SEC↗ |
| Sousa Ben | Chief Information Officer | M Exercise deriv | 2026-03-08 | 2026-03-09 | 957 | — | $0 | 3,775 | SEC↗ |
| Sousa Ben | Chief Information Officer | M Exercise deriv | 2026-03-08 | 2026-03-09 | 7,177 | — | $0 | 0 | SEC↗ |
| Jain Vivek | Chairman and CEO | M Exercise deriv | 2026-03-08 | 2026-03-09 | 107,635 | — | $0 | 0 | SEC↗ |
| Bonnell Brian Michael | Chief Financial Officer | M Exercise deriv | 2026-03-08 | 2026-03-09 | 71,757 | — | $0 | 0 | SEC↗ |
| Voigtlander Christian B. | Chief Operating Officer | F Tax w/h | 2026-03-08 | 2026-03-09 | 39,667 | $132.00 | $5.24M | 39,754 | SEC↗ |
| Voigtlander Christian B. | Chief Operating Officer | M Exercise | 2026-03-08 | 2026-03-09 | 71,757 | — | $0 | 79,421 | SEC↗ |
| Woolson Daniel | VP, GM-Infusion Capital | F Tax w/h | 2026-03-08 | 2026-03-09 | 6,877 | $132.00 | $907.8K | 21,450 | SEC↗ |
| Woolson Daniel | VP, GM-Infusion Capital | M Exercise | 2026-03-08 | 2026-03-09 | 16,147 | — | $0 | 28,327 | SEC↗ |
| Woolson Daniel | VP, GM-Infusion Capital | M Exercise | 2026-03-08 | 2026-03-09 | 2,153 | — | $0 | 23,603 | SEC↗ |
| Woolson Daniel | VP, GM-Infusion Capital | F Tax w/h | 2026-03-08 | 2026-03-09 | 630 | $132.00 | $83.2K | 22,973 | SEC↗ |
| Sanzone Virginia Ruth | VP, General Counsel | M Exercise | 2026-03-08 | 2026-03-09 | 23,917 | — | $0 | 30,424 | SEC↗ |
| Sanzone Virginia Ruth | VP, General Counsel | F Tax w/h | 2026-03-08 | 2026-03-09 | 13,221 | $132.00 | $1.75M | 17,203 | SEC↗ |
| Sanzone Virginia Ruth | VP, General Counsel | F Tax w/h | 2026-03-08 | 2026-03-09 | 1,762 | $132.00 | $232.6K | 18,630 | SEC↗ |
| Sanzone Virginia Ruth | VP, General Counsel | M Exercise | 2026-03-08 | 2026-03-09 | 3,189 | — | $0 | 20,392 | SEC↗ |
| Sousa Ben | Chief Information Officer | F Tax w/h | 2026-03-08 | 2026-03-09 | 529 | $132.00 | $69.8K | 4,744 | SEC↗ |
| Sousa Ben | Chief Information Officer | M Exercise | 2026-03-08 | 2026-03-09 | 957 | — | $0 | 5,273 | SEC↗ |
| Sousa Ben | Chief Information Officer | F Tax w/h | 2026-03-08 | 2026-03-09 | 3,967 | $132.00 | $523.6K | 4,316 | SEC↗ |
| Sousa Ben | Chief Information Officer | M Exercise | 2026-03-08 | 2026-03-09 | 7,177 | — | $0 | 8,283 | SEC↗ |
| Jain Vivek | Chairman and CEO | F Tax w/h | 2026-03-08 | 2026-03-09 | 59,500 | $132.00 | $7.85M | 117,006 | SEC↗ |
| Jain Vivek | Chairman and CEO | M Exercise | 2026-03-08 | 2026-03-09 | 107,635 | — | $0 | 176,506 | SEC↗ |
| Bonnell Brian Michael | Chief Financial Officer | M Exercise | 2026-03-08 | 2026-03-09 | 71,757 | — | $0 | 104,364 | SEC↗ |
| Bonnell Brian Michael | Chief Financial Officer | F Tax w/h | 2026-03-08 | 2026-03-09 | 39,667 | $132.00 | $5.24M | 64,697 | SEC↗ |
| Voigtlander Christian B. | Chief Operating Officer | M Exercise deriv | 2026-03-07 | 2026-03-09 | 3,522 | — | $0 | 7,044 | SEC↗ |
| Woolson Daniel | VP, GM-Infusion Capital | M Exercise deriv | 2026-03-07 | 2026-03-09 | 1,585 | — | $0 | 3,170 | SEC↗ |
| Sanzone Virginia Ruth | VP, General Counsel | M Exercise deriv | 2026-03-07 | 2026-03-09 | 2,348 | — | $0 | 11,075 | SEC↗ |
| Sousa Ben | Chief Information Officer | M Exercise deriv | 2026-03-07 | 2026-03-09 | 1,409 | — | $0 | 4,732 | SEC↗ |
| Jain Vivek | Chairman and CEO | M Exercise deriv | 2026-03-07 | 2026-03-09 | 5,282 | — | $0 | 10,566 | SEC↗ |
| Bonnell Brian Michael | Chief Financial Officer | M Exercise deriv | 2026-03-07 | 2026-03-09 | 3,522 | — | $0 | 7,044 | SEC↗ |
| Voigtlander Christian B. | Chief Operating Officer | M Exercise | 2026-03-07 | 2026-03-09 | 3,522 | — | $0 | 9,610 | SEC↗ |
| Voigtlander Christian B. | Chief Operating Officer | F Tax w/h | 2026-03-07 | 2026-03-09 | 1,946 | $132.00 | $256.9K | 7,664 | SEC↗ |
| Woolson Daniel | VP, GM-Infusion Capital | M Exercise | 2026-03-07 | 2026-03-09 | 1,585 | — | $0 | 12,882 | SEC↗ |
| Woolson Daniel | VP, GM-Infusion Capital | F Tax w/h | 2026-03-07 | 2026-03-09 | 702 | $132.00 | $92.7K | 12,180 | SEC↗ |
| Sanzone Virginia Ruth | VP, General Counsel | F Tax w/h | 2026-03-07 | 2026-03-09 | 1,297 | $132.00 | $171.2K | 6,507 | SEC↗ |
| Sanzone Virginia Ruth | VP, General Counsel | M Exercise | 2026-03-07 | 2026-03-09 | 2,348 | — | $0 | 7,804 | SEC↗ |
| Sousa Ben | Chief Information Officer | F Tax w/h | 2026-03-07 | 2026-03-09 | 782 | $132.00 | $103.2K | 1,106 | SEC↗ |
| Sousa Ben | Chief Information Officer | M Exercise | 2026-03-07 | 2026-03-09 | 1,409 | — | $0 | 1,888 | SEC↗ |
| Jain Vivek | Chairman and CEO | M Exercise | 2026-03-07 | 2026-03-09 | 5,282 | — | $0 | 71,790 | SEC↗ |
| Jain Vivek | Chairman and CEO | F Tax w/h | 2026-03-07 | 2026-03-09 | 2,919 | — | $0 | 68,871 | SEC↗ |
| Bonnell Brian Michael | Chief Financial Officer | F Tax w/h | 2026-03-07 | 2026-03-09 | 1,263 | — | $0 | 32,607 | SEC↗ |
| Bonnell Brian Michael | Chief Financial Officer | M Exercise | 2026-03-07 | 2026-03-09 | 3,522 | — | $0 | 33,870 | SEC↗ |
| Woolson Daniel | VP, GM-Infusion Capital | S Sale | 2025-11-25 | 2025-11-25 | 2,897 | $152.35 | $441.4K | 11,297 | SEC↗ |
| FINNEY ELISHA W | Director | M Exercise deriv | 2025-11-11 | 2025-11-12 | 1,285 | — | $0 | 0 | SEC↗ |
| Sanzone Virginia Ruth | VP, General Counsel | S Sale | 2025-11-11 | 2025-11-12 | 930 | $142.35 | $132.4K | 5,456 | SEC↗ |
| FINNEY ELISHA W | Director | S Sale | 2025-11-11 | 2025-11-12 | 1,285 | $140.42 | $180.4K | 3,995 | SEC↗ |
| FINNEY ELISHA W | Director | M Exercise | 2025-11-11 | 2025-11-12 | 1,285 | $103.76 | $133.3K | 5,280 | SEC↗ |
| Jain Vivek | Chairman and CEO | G Gift | 2025-09-12 | 2025-09-15 | 63,641 | — | $0 | 66,508 | SEC↗ |
| Jain Vivek | Chairman and CEO | G Gift | 2025-09-12 | 2025-09-15 | 63,641 | — | $0 | 152,339 | SEC↗ |
| Greenberg David C. | Director | P Buy | 2025-08-27 | 2025-08-27 | 598 | $126.69 | $75.8K | 7,960 | SEC↗ |
| Greenberg David C. | Director | P Buy | 2025-08-27 | 2025-08-27 | 602 | $126.14 | $75.9K | 7,362 | SEC↗ |
| Jain Vivek | Chairman and CEO | P Buy | 2025-08-14 | 2025-08-14 | 2,378 | $112.12 | $266.6K | 110,598 | SEC↗ |
| Jain Vivek | Chairman and CEO | P Buy | 2025-08-14 | 2025-08-14 | 19,551 | $112.92 | $2.21M | 130,149 | SEC↗ |
| Sanzone Virginia Ruth | VP, General Counsel | S Sale | 2025-05-30 | 2025-05-30 | 700 | $133.62 | $93.5K | 6,386 | SEC↗ |
| Voigtlander Christian B. | Chief Operating Officer | M Exercise deriv | 2025-05-28 | 2025-05-28 | 5,560 | — | $0 | 0 | SEC↗ |
| Voigtlander Christian B. | Chief Operating Officer | S Sale | 2025-05-28 | 2025-05-28 | 4,985 | $128.50 | $640.6K | 6,088 | SEC↗ |
| Voigtlander Christian B. | Chief Operating Officer | M Exercise | 2025-05-28 | 2025-05-28 | 5,560 | $96.83 | $538.4K | 11,073 | SEC↗ |
| Voigtlander Christian B. | Chief Operating Officer | M Exercise deriv | 2025-05-27 | 2025-05-28 | 5,555 | — | $0 | 5,560 | SEC↗ |
| Voigtlander Christian B. | Chief Operating Officer | M Exercise | 2025-05-27 | 2025-05-28 | 5,555 | $96.83 | $537.9K | 10,458 | SEC↗ |
| Voigtlander Christian B. | Chief Operating Officer | S Sale | 2025-05-27 | 2025-05-28 | 4,945 | $131.00 | $647.8K | 5,513 | SEC↗ |
| Voigtlander Christian B. | Chief Operating Officer | M Exercise deriv | 2025-05-23 | 2025-05-23 | 5,555 | — | $0 | 11,115 | SEC↗ |
| Voigtlander Christian B. | Chief Operating Officer | S Sale | 2025-05-23 | 2025-05-23 | 4,959 | $130.00 | $644.7K | 4,903 | SEC↗ |
| Voigtlander Christian B. | Chief Operating Officer | M Exercise | 2025-05-23 | 2025-05-23 | 5,555 | $96.83 | $537.9K | 9,862 | SEC↗ |
| Voigtlander Christian B. | Chief Operating Officer | M Exercise deriv | 2025-05-22 | 2025-05-23 | 5,555 | — | $0 | 16,670 | SEC↗ |
| Voigtlander Christian B. | Chief Operating Officer | M Exercise | 2025-05-22 | 2025-05-23 | 5,555 | $96.83 | $537.9K | 9,266 | SEC↗ |
| Voigtlander Christian B. | Chief Operating Officer | S Sale | 2025-05-22 | 2025-05-23 | 4,959 | $130.03 | $644.8K | 4,307 | SEC↗ |
| Voigtlander Christian B. | Chief Operating Officer | M Exercise deriv | 2025-05-21 | 2025-05-21 | 5,555 | — | $0 | 22,225 | SEC↗ |
| Voigtlander Christian B. | Chief Operating Officer | S Sale | 2025-05-21 | 2025-05-21 | 4,917 | $133.00 | $654.0K | 3,711 | SEC↗ |
| Voigtlander Christian B. | Chief Operating Officer | M Exercise | 2025-05-21 | 2025-05-21 | 5,555 | $96.83 | $537.9K | 8,628 | SEC↗ |
| Voigtlander Christian B. | Chief Operating Officer | M Exercise deriv | 2025-05-20 | 2025-05-21 | 5,555 | — | $0 | 27,780 | SEC↗ |
| Voigtlander Christian B. | Chief Operating Officer | S Sale | 2025-05-20 | 2025-05-21 | 4,871 | $137.11 | $667.9K | 3,073 | SEC↗ |
| Voigtlander Christian B. | Chief Operating Officer | M Exercise | 2025-05-20 | 2025-05-21 | 5,555 | $96.83 | $537.9K | 7,944 | SEC↗ |
| Voigtlander Christian B. | Chief Operating Officer | M Exercise deriv | 2025-05-19 | 2025-05-19 | 5,555 | — | $0 | 33,335 | SEC↗ |
| Voigtlander Christian B. | Chief Operating Officer | S Sale | 2025-05-19 | 2025-05-19 | 5,555 | $138.00 | $766.6K | 2,389 | SEC↗ |
| Voigtlander Christian B. | Chief Operating Officer | M Exercise | 2025-05-19 | 2025-05-19 | 5,555 | $96.83 | $537.9K | 7,944 | SEC↗ |
| FINNEY ELISHA W | Director | S Sale | 2025-05-19 | 2025-05-20 | 600 | $138.92 | $83.4K | 3,252 | SEC↗ |
| Voigtlander Christian B. | Chief Operating Officer | M Exercise deriv | 2025-05-16 | 2025-05-19 | 5,555 | — | $0 | 38,890 | SEC↗ |
| Voigtlander Christian B. | Chief Operating Officer | S Sale | 2025-05-16 | 2025-05-19 | 5,555 | $140.00 | $777.7K | 2,389 | SEC↗ |
| Voigtlander Christian B. | Chief Operating Officer | M Exercise | 2025-05-16 | 2025-05-19 | 5,555 | $96.83 | $537.9K | 7,944 | SEC↗ |
| Voigtlander Christian B. | Chief Operating Officer | M Exercise deriv | 2025-05-15 | 2025-05-15 | 5,555 | — | $0 | 44,445 | SEC↗ |
| Sousa Ben | Chief Information Officer | S Sale | 2025-05-15 | 2025-05-15 | 2,000 | $137.36 | $274.7K | 479 | SEC↗ |
| Voigtlander Christian B. | Chief Operating Officer | M Exercise | 2025-05-15 | 2025-05-15 | 5,555 | $96.83 | $537.9K | 7,944 | SEC↗ |
| Voigtlander Christian B. | Chief Operating Officer | S Sale | 2025-05-15 | 2025-05-15 | 5,555 | $135.55 | $753.0K | 2,389 | SEC↗ |
| Voigtlander Christian B. | Chief Operating Officer | M Exercise deriv | 2025-05-14 | 2025-05-15 | 5,556 | — | $0 | 50,000 | SEC↗ |
| Voigtlander Christian B. | Chief Operating Officer | M Exercise | 2025-05-14 | 2025-05-15 | 5,556 | $96.83 | $538.0K | 7,945 | SEC↗ |
| Voigtlander Christian B. | Chief Operating Officer | S Sale | 2025-05-14 | 2025-05-15 | 5,556 | $138.65 | $770.3K | 2,389 | SEC↗ |
| Greenberg David C. | Director | A Award deriv | 2025-05-13 | 2025-05-13 | 1,254 | — | $0 | 1,254 | SEC↗ |
| Greenberg David C. | Director | M Exercise deriv | 2025-05-13 | 2025-05-13 | 1,723 | — | $0 | 0 | SEC↗ |
| Greenberg David C. | Director | M Exercise deriv | 2025-05-13 | 2025-05-13 | 1,942 | — | $0 | 0 | SEC↗ |
| Hernandez Laurie | Director | A Award deriv | 2025-05-13 | 2025-05-13 | 1,254 | — | $0 | 1,254 | SEC↗ |
| Hernandez Laurie | Director | M Exercise deriv | 2025-05-13 | 2025-05-13 | 1,723 | — | $0 | 0 | SEC↗ |
| Abbey Donald | Director | M Exercise deriv | 2025-05-13 | 2025-05-13 | 1,723 | — | $0 | 0 | SEC↗ |
| Abbey Donald | Director | A Award deriv | 2025-05-13 | 2025-05-13 | 1,254 | — | $0 | 1,254 | SEC↗ |
| Hoffmeister David F | Director | A Award deriv | 2025-05-13 | 2025-05-13 | 1,254 | — | $0 | 1,254 | SEC↗ |
| Hoffmeister David F | Director | M Exercise deriv | 2025-05-13 | 2025-05-13 | 1,723 | — | $0 | 0 | SEC↗ |
| KENNEDY KOLLEEN T | Director | M Exercise deriv | 2025-05-13 | 2025-05-13 | 1,723 | — | $0 | 0 | SEC↗ |
| KENNEDY KOLLEEN T | Director | A Award deriv | 2025-05-13 | 2025-05-13 | 1,254 | — | $0 | 1,254 | SEC↗ |
| FINNEY ELISHA W | Director | M Exercise deriv | 2025-05-13 | 2025-05-14 | 1,723 | — | $0 | 0 | SEC↗ |
| FINNEY ELISHA W | Director | A Award deriv | 2025-05-13 | 2025-05-14 | 1,254 | — | $0 | 1,254 | SEC↗ |
| Greenberg David C. | Director | M Exercise | 2025-05-13 | 2025-05-13 | 1,942 | $94.68 | $183.9K | 8,702 | SEC↗ |
| Greenberg David C. | Director | M Exercise | 2025-05-13 | 2025-05-13 | 1,723 | — | $0 | 6,760 | SEC↗ |
| Greenberg David C. | Director | S Sale | 2025-05-13 | 2025-05-13 | 1,942 | $143.66 | $279.0K | 6,760 | SEC↗ |
| Hernandez Laurie | Director | M Exercise | 2025-05-13 | 2025-05-13 | 1,723 | — | $0 | 3,608 | SEC↗ |
| Abbey Donald | Director | M Exercise | 2025-05-13 | 2025-05-13 | 1,723 | — | $0 | 4,750 | SEC↗ |
| Hoffmeister David F | Director | M Exercise | 2025-05-13 | 2025-05-13 | 1,723 | — | $0 | 4,750 | SEC↗ |
| KENNEDY KOLLEEN T | Director | M Exercise | 2025-05-13 | 2025-05-13 | 1,723 | — | $0 | 3,285 | SEC↗ |
| FINNEY ELISHA W | Director | M Exercise | 2025-05-13 | 2025-05-14 | 1,723 | — | $0 | 3,852 | SEC↗ |
| Woolson Daniel | VP, GM-Infusion Capital | M Exercise deriv | 2025-03-15 | 2025-03-17 | 2,923 | — | $0 | 2,924 | SEC↗ |
| Voigtlander Christian B. | Chief Operating Officer | M Exercise deriv | 2025-03-15 | 2025-03-17 | 3,248 | — | $0 | 3,248 | SEC↗ |
| Sousa Ben | Chief Information Officer | M Exercise deriv | 2025-03-15 | 2025-03-17 | 1,299 | — | $0 | 1,300 | SEC↗ |
| Sanzone Virginia Ruth | VP, General Counsel | M Exercise deriv | 2025-03-15 | 2025-03-17 | 1,624 | — | $0 | 1,624 | SEC↗ |
| Jain Vivek | Chairman and CEO | M Exercise deriv | 2025-03-15 | 2025-03-17 | 4,872 | — | $0 | 4,872 | SEC↗ |
| Bonnell Brian Michael | Chief Financial Officer | M Exercise deriv | 2025-03-15 | 2025-03-17 | 3,248 | — | $0 | 3,248 | SEC↗ |
| Woolson Daniel | VP, GM-Infusion Capital | F Tax w/h | 2025-03-15 | 2025-03-17 | 1,294 | $143.45 | $185.6K | 14,194 | SEC↗ |
| Woolson Daniel | VP, GM-Infusion Capital | M Exercise | 2025-03-15 | 2025-03-17 | 2,923 | — | $0 | 15,488 | SEC↗ |
| Voigtlander Christian B. | Chief Operating Officer | M Exercise | 2025-03-15 | 2025-03-17 | 3,248 | — | $0 | 4,181 | SEC↗ |
| Voigtlander Christian B. | Chief Operating Officer | F Tax w/h | 2025-03-15 | 2025-03-17 | 1,792 | $143.45 | $257.1K | 2,389 | SEC↗ |
| Sousa Ben | Chief Information Officer | F Tax w/h | 2025-03-15 | 2025-03-17 | 716 | $143.45 | $102.7K | 2,479 | SEC↗ |
| Sousa Ben | Chief Information Officer | M Exercise | 2025-03-15 | 2025-03-17 | 1,299 | — | $0 | 3,195 | SEC↗ |
| Sanzone Virginia Ruth | VP, General Counsel | M Exercise | 2025-03-15 | 2025-03-17 | 1,624 | — | $0 | 7,984 | SEC↗ |
| Sanzone Virginia Ruth | VP, General Counsel | F Tax w/h | 2025-03-15 | 2025-03-17 | 898 | $143.45 | $128.8K | 7,086 | SEC↗ |
| Jain Vivek | Chairman and CEO | F Tax w/h | 2025-03-15 | 2025-03-17 | 2,688 | $143.45 | $385.6K | 108,220 | SEC↗ |
| Jain Vivek | Chairman and CEO | M Exercise | 2025-03-15 | 2025-03-17 | 4,872 | — | $0 | 110,908 | SEC↗ |
| Bonnell Brian Michael | Chief Financial Officer | M Exercise | 2025-03-15 | 2025-03-17 | 3,248 | — | $0 | 30,348 | SEC↗ |
| Woolson Daniel | VP, GM-Infusion Capital | M Exercise deriv | 2025-03-08 | 2025-03-10 | 2,153 | — | $0 | 9,061 | SEC↗ |
| Sousa Ben | Chief Information Officer | M Exercise deriv | 2025-03-08 | 2025-03-10 | 957 | — | $0 | 6,141 | SEC↗ |
| Sanzone Virginia Ruth | VP, General Counsel | M Exercise deriv | 2025-03-08 | 2025-03-10 | 3,189 | — | $0 | 13,423 | SEC↗ |
| Woolson Daniel | VP, GM-Infusion Capital | F Tax w/h | 2025-03-08 | 2025-03-10 | 953 | $141.97 | $135.3K | 12,565 | SEC↗ |
| Woolson Daniel | VP, GM-Infusion Capital | M Exercise | 2025-03-08 | 2025-03-10 | 2,153 | — | $0 | 13,518 | SEC↗ |
| Sousa Ben | Chief Information Officer | M Exercise | 2025-03-08 | 2025-03-10 | 957 | — | $0 | 2,446 | SEC↗ |
| Sousa Ben | Chief Information Officer | F Tax w/h | 2025-03-08 | 2025-03-10 | 550 | $141.97 | $78.1K | 1,896 | SEC↗ |
| Sanzone Virginia Ruth | VP, General Counsel | M Exercise | 2025-03-08 | 2025-03-10 | 3,189 | — | $0 | 8,119 | SEC↗ |
| Sanzone Virginia Ruth | VP, General Counsel | F Tax w/h | 2025-03-08 | 2025-03-10 | 1,759 | $141.97 | $249.7K | 6,360 | SEC↗ |
| Bonnell Brian Michael | Chief Financial Officer | M Exercise deriv | 2025-03-07 | 2025-03-10 | 2,146 | — | $0 | 0 | SEC↗ |
| Bonnell Brian Michael | Chief Financial Officer | A Award deriv | 2025-03-07 | 2025-03-10 | 10,566 | — | $0 | 10,566 | SEC↗ |
| Voigtlander Christian B. | Chief Operating Officer | A Award deriv | 2025-03-07 | 2025-03-10 | 10,566 | — | $0 | 10,566 | SEC↗ |
| Voigtlander Christian B. | Chief Operating Officer | M Exercise deriv | 2025-03-07 | 2025-03-10 | 2,146 | — | $0 | 0 | SEC↗ |
| Woolson Daniel | VP, GM-Infusion Capital | M Exercise deriv | 2025-03-07 | 2025-03-10 | 966 | — | $0 | 0 | SEC↗ |
| Woolson Daniel | VP, GM-Infusion Capital | A Award deriv | 2025-03-07 | 2025-03-10 | 4,755 | — | $0 | 11,214 | SEC↗ |
| Sousa Ben | Chief Information Officer | M Exercise deriv | 2025-03-07 | 2025-03-10 | 430 | — | $0 | 0 | SEC↗ |
| Sousa Ben | Chief Information Officer | A Award deriv | 2025-03-07 | 2025-03-10 | 4,227 | — | $0 | 7,098 | SEC↗ |
| Jain Vivek | Chairman and CEO | M Exercise deriv | 2025-03-07 | 2025-03-10 | 3,218 | — | $0 | 0 | SEC↗ |
| Sanzone Virginia Ruth | VP, General Counsel | M Exercise deriv | 2025-03-07 | 2025-03-10 | 1,073 | — | $0 | 0 | SEC↗ |
| Sanzone Virginia Ruth | VP, General Counsel | A Award deriv | 2025-03-07 | 2025-03-10 | 7,044 | — | $0 | 16,612 | SEC↗ |
| Jain Vivek | Chairman and CEO | A Award deriv | 2025-03-07 | 2025-03-14 | 15,848 | — | $0 | 15,848 | SEC↗ |
| Bonnell Brian Michael | Chief Financial Officer | M Exercise | 2025-03-07 | 2025-03-10 | 2,146 | — | $0 | 27,100 | SEC↗ |
| Voigtlander Christian B. | Chief Operating Officer | F Tax w/h | 2025-03-07 | 2025-03-10 | 1,213 | $141.97 | $172.2K | 933 | SEC↗ |
| Voigtlander Christian B. | Chief Operating Officer | M Exercise | 2025-03-07 | 2025-03-10 | 2,146 | — | $0 | 2,146 | SEC↗ |
| Woolson Daniel | VP, GM-Infusion Capital | M Exercise | 2025-03-07 | 2025-03-10 | 966 | — | $0 | 11,832 | SEC↗ |
| Woolson Daniel | VP, GM-Infusion Capital | F Tax w/h | 2025-03-07 | 2025-03-10 | 467 | $141.97 | $66.3K | 11,365 | SEC↗ |
| Sousa Ben | Chief Information Officer | F Tax w/h | 2025-03-07 | 2025-03-10 | 260 | $141.97 | $36.9K | 1,489 | SEC↗ |
| Sousa Ben | Chief Information Officer | M Exercise | 2025-03-07 | 2025-03-10 | 430 | — | $0 | 1,749 | SEC↗ |
| Jain Vivek | Chairman and CEO | F Tax w/h | 2025-03-07 | 2025-03-10 | 1,775 | — | $0 | 102,818 | SEC↗ |
| Jain Vivek | Chairman and CEO | M Exercise | 2025-03-07 | 2025-03-10 | 3,218 | — | $0 | 106,036 | SEC↗ |
| Sanzone Virginia Ruth | VP, General Counsel | F Tax w/h | 2025-03-07 | 2025-03-10 | 625 | $141.97 | $88.7K | 4,930 | SEC↗ |
| Sanzone Virginia Ruth | VP, General Counsel | M Exercise | 2025-03-07 | 2025-03-10 | 1,073 | — | $0 | 5,555 | SEC↗ |
| Jain Vivek | Chairman and CEO | M Exercise deriv | 2025-01-02 | 2025-01-02 | 1,373 | — | $0 | 0 | SEC↗ |
| Jain Vivek | Chairman and CEO | S Sale | 2025-01-02 | 2025-01-02 | 1,373 | $155.48 | $213.5K | 104,593 | SEC↗ |
| Jain Vivek | Chairman and CEO | M Exercise | 2025-01-02 | 2025-01-02 | 1,373 | $88.76 | $121.9K | 105,966 | SEC↗ |
| Woolson Daniel | VP, GM-Infusion Capital | S Sale | 2024-12-06 | 2024-12-06 | 2,241 | $156.25 | $350.2K | 10,866 | SEC↗ |
| Jain Vivek | Chairman and CEO | M Exercise deriv | 2024-12-02 | 2024-12-02 | 12,000 | — | $0 | 1,373 | SEC↗ |
| Jain Vivek | Chairman and CEO | S Sale | 2024-12-02 | 2024-12-02 | 78 | $163.96 | $12.8K | 104,593 | SEC↗ |
| Jain Vivek | Chairman and CEO | S Sale | 2024-12-02 | 2024-12-02 | 8,250 | $163.18 | $1.35M | 104,671 | SEC↗ |
| Jain Vivek | Chairman and CEO | S Sale | 2024-12-02 | 2024-12-02 | 3,672 | $162.29 | $595.9K | 112,921 | SEC↗ |
| Jain Vivek | Chairman and CEO | M Exercise | 2024-12-02 | 2024-12-02 | 12,000 | $88.76 | $1.07M | 116,593 | SEC↗ |
| Voigtlander Christian B. | Chief Operating Officer | M Exercise deriv | 2024-11-27 | 2024-11-27 | 1,430 | — | $0 | 55,556 | SEC↗ |
| Greenberg David C. | Director | M Exercise deriv | 2024-11-27 | 2024-11-27 | 972 | — | $0 | 1,942 | SEC↗ |
| Voigtlander Christian B. | Chief Operating Officer | S Sale | 2024-11-27 | 2024-11-27 | 1,430 | $158.00 | $225.9K | 0 | SEC↗ |
| Voigtlander Christian B. | Chief Operating Officer | M Exercise | 2024-11-27 | 2024-11-27 | 1,430 | $96.83 | $138.5K | 1,430 | SEC↗ |
| Greenberg David C. | Director | S Sale | 2024-11-27 | 2024-11-27 | 972 | $158.11 | $153.7K | 5,037 | SEC↗ |
| Greenberg David C. | Director | M Exercise | 2024-11-27 | 2024-11-27 | 972 | $94.68 | $92.0K | 6,009 | SEC↗ |
| Voigtlander Christian B. | Chief Operating Officer | M Exercise deriv | 2024-11-26 | 2024-11-26 | 7,719 | — | $0 | 56,986 | SEC↗ |
| Voigtlander Christian B. | Chief Operating Officer | S Sale | 2024-11-26 | 2024-11-26 | 206 | $160.09 | $33.0K | 0 | SEC↗ |
| Voigtlander Christian B. | Chief Operating Officer | M Exercise | 2024-11-26 | 2024-11-26 | 7,719 | $96.83 | $747.4K | 7,719 | SEC↗ |
| Voigtlander Christian B. | Chief Operating Officer | S Sale | 2024-11-26 | 2024-11-26 | 7,513 | $159.09 | $1.20M | 206 | SEC↗ |
| Voigtlander Christian B. | Chief Operating Officer | M Exercise deriv | 2024-11-25 | 2024-11-26 | 1,962 | — | $0 | 64,705 | SEC↗ |
| Voigtlander Christian B. | Chief Operating Officer | S Sale | 2024-11-25 | 2024-11-26 | 1,962 | $169.08 | $331.7K | 0 | SEC↗ |
| Voigtlander Christian B. | Chief Operating Officer | M Exercise | 2024-11-25 | 2024-11-26 | 1,962 | $96.83 | $190.0K | 1,962 | SEC↗ |
| Jain Vivek | Chairman and CEO | M Exercise deriv | 2024-11-01 | 2024-11-04 | 12,000 | — | $0 | 13,373 | SEC↗ |
| Jain Vivek | Chairman and CEO | M Exercise | 2024-11-01 | 2024-11-04 | 12,000 | $88.76 | $1.07M | 116,593 | SEC↗ |
| Jain Vivek | Chairman and CEO | S Sale | 2024-11-01 | 2024-11-04 | 4,228 | $170.75 | $721.9K | 112,365 | SEC↗ |
| Jain Vivek | Chairman and CEO | S Sale | 2024-11-01 | 2024-11-04 | 4,147 | $171.91 | $712.9K | 108,218 | SEC↗ |
| Jain Vivek | Chairman and CEO | S Sale | 2024-11-01 | 2024-11-04 | 2,386 | $172.76 | $412.2K | 105,832 | SEC↗ |
| Jain Vivek | Chairman and CEO | S Sale | 2024-11-01 | 2024-11-04 | 1,239 | $173.60 | $215.1K | 104,593 | SEC↗ |
| Jain Vivek | Chairman and CEO | M Exercise deriv | 2024-10-01 | 2024-10-01 | 12,000 | — | $0 | 25,373 | SEC↗ |
| Jain Vivek | Chairman and CEO | S Sale | 2024-10-01 | 2024-10-01 | 3,375 | $179.16 | $604.7K | 105,381 | SEC↗ |
| Jain Vivek | Chairman and CEO | S Sale | 2024-10-01 | 2024-10-01 | 3,681 | $178.49 | $657.0K | 108,756 | SEC↗ |
| Jain Vivek | Chairman and CEO | S Sale | 2024-10-01 | 2024-10-01 | 788 | $180.48 | $142.2K | 104,593 | SEC↗ |
| Jain Vivek | Chairman and CEO | M Exercise | 2024-10-01 | 2024-10-01 | 12,000 | $88.76 | $1.07M | 116,593 | SEC↗ |
| Jain Vivek | Chairman and CEO | S Sale | 2024-10-01 | 2024-10-01 | 4,156 | $177.50 | $737.7K | 112,437 | SEC↗ |
| Jain Vivek | Chairman and CEO | M Exercise deriv | 2024-09-03 | 2024-09-03 | 3,805 | $88.76 | $337.7K | 37,373 | SEC↗ |
| Jain Vivek | Chairman and CEO | M Exercise deriv | 2024-09-03 | 2024-09-03 | 4,440 | $88.76 | $394.1K | 41,178 | SEC↗ |
| Jain Vivek | Chairman and CEO | M Exercise deriv | 2024-09-03 | 2024-09-03 | 3,755 | $88.76 | $333.3K | 45,618 | SEC↗ |
| Jain Vivek | Chairman and CEO | M Exercise | 2024-09-03 | 2024-09-03 | 3,755 | $88.76 | $333.3K | 108,348 | SEC↗ |
| Jain Vivek | Chairman and CEO | S Sale | 2024-09-03 | 2024-09-03 | 3,755 | $162.69 | $610.9K | 104,593 | SEC↗ |
| Jain Vivek | Chairman and CEO | M Exercise | 2024-09-03 | 2024-09-03 | 4,440 | $88.76 | $394.1K | 109,033 | SEC↗ |
| Jain Vivek | Chairman and CEO | S Sale | 2024-09-03 | 2024-09-03 | 4,440 | $163.59 | $726.3K | 104,593 | SEC↗ |
| Jain Vivek | Chairman and CEO | M Exercise | 2024-09-03 | 2024-09-03 | 3,805 | $88.76 | $337.7K | 108,398 | SEC↗ |
| Jain Vivek | Chairman and CEO | S Sale | 2024-09-03 | 2024-09-03 | 3,805 | $164.07 | $624.3K | 104,593 | SEC↗ |
| Woolson Daniel | VP, GM-Infusion Capital | S Sale | 2024-08-30 | 2024-08-30 | 2,502 | $163.22 | $408.4K | 13,107 | SEC↗ |
| Jain Vivek | Chairman and CEO | M Exercise deriv | 2024-08-16 | 2024-08-16 | 12,000 | — | $0 | 49,373 | SEC↗ |
| Jain Vivek | Chairman and CEO | S Sale | 2024-08-16 | 2024-08-16 | 12,000 | $156.04 | $1.87M | 104,593 | SEC↗ |
| Jain Vivek | Chairman and CEO | M Exercise | 2024-08-16 | 2024-08-16 | 12,000 | $88.76 | $1.07M | 116,593 | SEC↗ |
| Sanzone Virginia Ruth | VP, General Counsel | S Sale | 2024-08-08 | 2024-08-08 | 2,050 | $144.11 | $295.4K | 4,482 | SEC↗ |
| Voigtlander Christian B. | Chief Operating Officer | S Sale | 2024-05-30 | 2024-05-30 | 10,507 | $103.85 | $1.09M | 2,032 | SEC↗ |
| Voigtlander Christian B. | Chief Operating Officer | S Sale | 2024-05-30 | 2024-05-30 | 2,032 | $104.49 | $212.3K | 0 | SEC↗ |
| FINNEY ELISHA W | Director | S Sale | 2024-05-16 | 2024-05-16 | 300 | $104.95 | $31.5K | 2,129 | SEC↗ |
| Hernandez Laurie | Director | A Award deriv | 2024-05-15 | 2024-05-15 | 1,723 | — | $0 | 1,723 | SEC↗ |
| Hernandez Laurie | Director | M Exercise deriv | 2024-05-15 | 2024-05-15 | 948 | — | $0 | 0 | SEC↗ |
| Greenberg David C. | Director | A Award deriv | 2024-05-15 | 2024-05-15 | 1,723 | — | $0 | 1,723 | SEC↗ |
| Greenberg David C. | Director | M Exercise deriv | 2024-05-15 | 2024-05-15 | 948 | — | $0 | 0 | SEC↗ |
| FINNEY ELISHA W | Director | M Exercise deriv | 2024-05-15 | 2024-05-15 | 948 | — | $0 | 0 | SEC↗ |
| FINNEY ELISHA W | Director | A Award deriv | 2024-05-15 | 2024-05-15 | 1,723 | — | $0 | 0 | SEC↗ |
| Abbey Donald | Director | A Award deriv | 2024-05-15 | 2024-05-15 | 1,723 | — | $0 | 0 | SEC↗ |
| Abbey Donald | Director | M Exercise deriv | 2024-05-15 | 2024-05-15 | 948 | — | $0 | 0 | SEC↗ |
| KENNEDY KOLLEEN T | Director | A Award deriv | 2024-05-15 | 2024-05-15 | 1,723 | — | $0 | 0 | SEC↗ |
| KENNEDY KOLLEEN T | Director | M Exercise deriv | 2024-05-15 | 2024-05-15 | 948 | — | $0 | 0 | SEC↗ |